Validation of an in vitro teratology system using chiral substances: stereoselective teratogenicity of 4-yn-valproic acid in cultured mouse embryos.

No abstract is available for this paper.

• Publication year

  1995

• Venue

  Toxicology and Applied Pharmacology

• Publication date

  1995-06-01

• Fields of study

  Biology, Medicine, Chemistry

• Identifiers
  DOI 10.1006/TAAP.1995.1112PMID 7785058
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Pharmacokinetics of enantiomers of chiral non-steroidal anti-inflammatory drugs

  2010cited by this paper
• Effects of valproic acid, some of its metabolites and analogues on prenatal development of rats in vitro and comparison with effects in vivo

  2005cited by this paper
• Embryotoxic effects of thalidomide derivatives in the non-human primate Callithrix jacchus

  2004cited by this paper
• Valproic acid. A reappraisal of its pharmacological properties and clinical efficacy in epilepsy.

  1994cited by this paper
• Developmental toxicity and structure-activity relationships of aliphatic acids, including dose-response assessment of valproic acid in mice and rats.

  1994cited by this paper
• Stereoselectivity of biliary excretion of 2-arylpropionates in rats.

  1993cited by this paper
• Anticonvulsant and neurotoxic activities of twelve analogues of valproic acid.

  1993cited by this paper
• Commonly used chiral drugs: a survey.

  1993cited by this paper
• Developmental toxicity of methanol in whole embryo culture: a comparative study with mouse and rat embryos.

  1993cited by this paper
• Lowering pH increases embryonic sensitivity to formate in whole embryo culture.

  1993cited by this paper
• The enantioselective teratogenicity of 2-n-propyl-4-pentynoic acid (4-yn-VPA) is due to stereoselective intrinsic activity and not differences in pharmacokinetics.

  1992cited by this paper
• Valproic acid-induced spina bifida: a mouse model.

  1992cited by this paper
• The Enantiomers of the Valproic Acid Analogue 2-n-Propyl-4-pentynoic Acid (4-yn-VPA): Asymmetric Synthesis and Highly Stereoselective Teratogenicity in Mice

  1992cited by this paper
• The valproic acid metabolite E-2-n-propyl-2-pentenoic acid does not induce spina bifida in the mouse.

  1992cited by this paper
• On the development of alternative antiepileptic drugs

  1991cited by this paper
• Valproic acid-induced neural tube defects in mouse and human: aspects of chirality, alternative drug development, pharmacokinetics and possible mechanisms.

  1991cited by this paper
• Asymmetric synthesis and teratogenic activity of (R)- and (S)-2-ethylhexanoic acid, a metabolite of the plasticizer di-(2-ethylhexyl)phthalate.

  1990cited by this paper
• Morphogenesis and quantification of the development of post-implantation mouse embryos.

  1990cited by this paper
• Enantiomer specific pharmacokinetics.

  1990cited by this paper
• Asymmetric synthesis and enantioselective teratogenicity of 2-n-propyl-4-pentenoic acid (4-en-VPA), an active metabolite of the anticonvulsant drug, valproic acid.

  1989cited by this paper
• The metabolic chiral inversion and dispositional enantioselectivity of the 2-arylpropionic acids and their biological consequences.

  1988cited by this paper
• Pharmacokinetic aspects of drug effects in vitro (II) placental transfer to the embryo and activity of some carboxylic acids structurally related to valproic acid in whole embryos in culture.

  1988cited by this paper
• The enantiomers of the teratogenic thalidomide analogue EM 12: 1. Chiral inversion and plasma pharmacokinetics in the marmoset monkey.

  1988cited by this paper
• Stereoselectivity of bioactive xenobiotics. A pre-Pasteur attitude in medicinal chemistry, pharmacokinetics and clinical pharmacology.

  1988cited by this paper
• Pharmacologic evaluation of various metabolites and analogs of valproic acid: teratogenic potencies in mice.

  1986cited by this paper
• Transfer of valproic acid and its main active unsaturated metabolite to the gestational tissue: correlation with neural tube defect formation in the mouse.

  1986cited by this paper
• Valproic acid teratogenicity in mice after various administration and phenobarbital-pretreatment regimens: the parent drug and not one of the metabolites assayed is implicated as teratogen.

  1986cited by this paper
• Fetal growth, major malformations, and minor anomalies in infants born to women receiving valproic acid.

  1986cited by this paper
• Somatomedin Inhibitors From Diabetic Rat Serum Alter Growth and Development of Mouse Embryos in Culture

  1986cited by this paper
• Quantitation of rat embryonic development in vitro: a morphological scoring system.

  1981cited by this paper
• Valproic acid and its metabolites: placental transfer, neonatal pharmacokinetics, transfer via mother's milk and clinical status in neonates of epileptic mothers.

  1981cited by this paper
• A simplified microassay of DNA and RNA using ethidium bromide.

  1975cited by this paper
• Warfarin. Stereochemical aspects of its metabolism and the interaction with phenylbutazone.

  1974cited by this paper
• Protein measurement with the Folin phenol reagent.

  1951cited by this paper

• Use of polysaccharide-based chiral columns: enantiomeric separation of seven pairs of abused drugs by high-performance liquid chromatography–mass spectrometry

  2018cites this paper
• Chiral toxicology: it's the same thing...only different.

  2009cites this paper
• Article Title: Chiral Toxicology: It's the Same Thing…Only Different

  2009cites this paper
• REVIEW Chiral Toxicology: It's the Same Thing ... Only Different

  2009cites this paper
• Untersuchungen zur Bioaktivierung eines in vitro Embryotoxizitätstests mit embryonalen Stammzellen der Maus (Mus musculus L.)

  2008cites this paper
• Whole embryo culture: an important tool in developmental toxicology today.

  2006cites this paper
• Induction of the homeotic gene Hoxa1 through valproic acid's teratogenic mechanism of action.

  2006cites this paper
• (-)-Clausenamide potentiates synaptic transmission in the dentate gyrus of rats.

  2005cites this paper
• Predicting the risk of developmental toxicity from in vitro assays.

  2005cites this paper
• Effect of valproic acid on fetal and maternal organs in the mouse: a morphological study.

  2004cites this paper
• Alternatives to animal testing: research, trends, validation, regulatory acceptance.

  2003cites this paper
• Methods of in vitro toxicology.

  2002cites this paper
• Selection of Test Chemicals for the ECVAM International Validation Study on In Vitro Embryotoxicity Tests

  2002cites this paper
• Valproate and valproate-analogues: potent tools to fight against cancer.

  2002cites this paper
• Neural crest cell motility in valproic acid.

  2002cites this paper
• Postimplantation Whole Embryo Culture Assay for Hamsters: An Alternative to Rat and Mouse

  2001cites this paper
• New molecular bioassays for the estimation of the teratogenic potency of valproic acid derivatives in vitro: activation of the peroxisomal proliferator-activated receptor (PPARdelta).

  1999cites this paper
• Antiepileptic teratogen valproic acid (VPA) modulates organisation and dynamics of the actin cytoskeleton.

  1999cites this paper
• Valproate

  1999cites this paper
• Assessment of the U.S. Environmental Protection Agency methods for identification of hazards to developing organisms, Part II: The developmental toxicity testing guideline.

  1999cites this paper
• Reproduction and development.

  1998cites this paper
• Cell proliferation, migration and CAM-dependent neurite outgrowth as developmental in vitro endpoints for screening teratogenic potential: Application to valproic acid and related analogues of varying potency.

  1998cites this paper
• Cell motility is inhibited by the antiepileptic compound, valproic acid and its teratogenic analogues.

  1998cites this paper
• Evaluation of the Teratogenic Potential of Valproic Acid Analogues in Transgenic Dictyostelium discoideum Strains.

  1998cites this paper
• Stereoselective dysmorphogenicity of the enantiomers of the valproic acid analogue 2-N-propyl-4-pentynoic acid (4-yn-VPA): cross-species evaluation in whole embryo culture.

  1997cites this paper
• Prediction of teratogenic potency of valproate analogues using cerebellar aggregation cultures.

  1997cites this paper
• Pharmacological Importance of Stereochemical Resolution of Enantiomeric Drugs

  1997cites this paper
• Further branching of valproate-related carboxylic acids reduces the teratogenic activity, but not the anticonvulsant effect.

  1996cites this paper
• Teratogenic potency of valproate analogues evaluated by quantitative estimation of cellular morphology in vitro.

  1996cites this paper
• Inhibition of insulin-induced chondrogenic differentiation of embryonic carcinoma cells by a teratogenic compound YM9429.

  1996cites this paper
• Screening Chemicals for Reproductive Toxicity: The Current Alternatives

  1995cites this paper